UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Letter to the Editor: “Cortisol Secretion, Sensitivity, and Activity Are Associated with Hypertension in Postmenopausal Eucortisolemic Women”

The journal of clinical endocrinology and metabolism, 2020-01, Vol.105 (1), p.374-375

2020

Volltextzugriff (PDF)

High‐Intensity Resistance and Impact Training Improves Bone Mineral Density and Physical Function in Postmenopausal Women With Osteopenia and Osteoporosis: The LIFTMOR Randomized Controlled Trial

Journal of bone and mineral research, 2018-02, Vol.33 (2), p.211-220

2018

Volltextzugriff (PDF)

The Menopause Transition: Signs, Symptoms, and Management Options

The journal of clinical endocrinology and metabolism, 2021-01, Vol.106 (1), p.1-15

2021

Volltextzugriff (PDF)

One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study

Journal of bone and mineral research, 2019-03, Vol.34 (3), p.419-428

2019

Volltextzugriff (PDF)

Review: Diabetes, Obesity, and Cancer—Pathophysiology and Clinical Implications

Endocrine reviews, 2020-02, Vol.41 (1), p.33-52

2020

Volltextzugriff (PDF)

ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis

The journal of clinical endocrinology and metabolism, 2018-08, Vol.103 (8), p.2949-2957

2018

Volltextzugriff (PDF)

Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update

The journal of clinical endocrinology and metabolism, 2020-03, Vol.105 (3), p.587-594

2020

Volltextzugriff (PDF)

Clinical Features of 24 Patients With Rebound‐Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases

Journal of bone and mineral research, 2017-06, Vol.32 (6), p.1291-1296

2017

Volltextzugriff (PDF)

Bone Mineral Density After Transitioning From Denosumab to Alendronate

The journal of clinical endocrinology and metabolism, 2020-03, Vol.105 (3), p.e255-e264

2020

Volltextzugriff (PDF)

Early menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: a systematic review and meta-analysis

European journal of endocrinology, 2019-01, Vol.180 (1), p.41-50

2019

Volltextzugriff (PDF)

Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline

The journal of clinical endocrinology and metabolism, 2019-05, Vol.104 (5), p.1595-1622

2019

Volltextzugriff (PDF)

FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab

Journal of bone and mineral research, 2018-07, Vol.33 (7), p.1219-1226

2018

Volltextzugriff (PDF)

A Single Infusion of Zoledronate in Postmenopausal Women Following Denosumab Discontinuation Results in Partial Conservation of Bone Mass Gains

Journal of bone and mineral research, 2020-07, Vol.35 (7), p.1207-1215

2020

Volltextzugriff (PDF)

Calcifediol Is Not Superior to Cholecalciferol in Improving Vitamin D Status in Postmenopausal Women

Journal of bone and mineral research, 2022-07, Vol.37 (7), p.1411-1412

2022

Volltextzugriff (PDF)

Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double‐Blind, Phase 2, Parallel Group Study

Journal of bone and mineral research, 2018-08, Vol.33 (8), p.1397-1406

2018

Volltextzugriff (PDF)

Secondary Osteoporosis

Endocrine reviews, 2022-04, Vol.43 (2), p.240-313

2022

Volltextzugriff (PDF)

Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2‐Year Clinical Trial

Journal of bone and mineral research, 2019-12, Vol.34 (12), p.2220-2228

2019

Volltextzugriff (PDF)

Reply to Calcifediol Is Not Superior to Cholecalciferol in Improving Vitamin D Status in Postmenopausal Women

Journal of bone and mineral research, 2022-07, Vol.37 (7), p.1413-1415

2022

Volltextzugriff (PDF)

Sclerostin Regulation, Microarchitecture, and Advanced Glycation End‐Products in the Bone of Elderly Women With Type 2 Diabetes

Journal of bone and mineral research, 2020-12, Vol.35 (12), p.2415-2422

2020

Volltextzugriff (PDF)

Bone‐Forming and Antiresorptive Effects of Romosozumab in Postmenopausal Women With Osteoporosis: Bone Histomorphometry and Microcomputed Tomography Analysis After 2 and 12 Months of Treatment

Journal of bone and mineral research, 2019-09, Vol.34 (9), p.1597-1608

2019

Volltextzugriff (PDF)

DDT and Breast Cancer: Prospective Study of Induction Time and Susceptibility Windows

JNCI : Journal of the National Cancer Institute, 2019-08, Vol.111 (8), p.803-810

2019

Volltextzugriff (PDF)

DIAGNOSIS OF ENDOCRINE DISEASE: Evaluation of bone fragility in endocrine disorders

European journal of endocrinology, 2019-06, Vol.180 (6), p.R213-R232

2019

Volltextzugriff (PDF)

Sex-specific Estrogen Levels and Reference Intervals from Infancy to Late Adulthood Determined by LC-MS/MS

The journal of clinical endocrinology and metabolism, 2020-03, Vol.105 (3), p.754-768

2020

Volltextzugriff (PDF)

Epidemiology, Pathophysiology, and Genetics of Primary Hyperparathyroidism

Journal of bone and mineral research, 2022-11, Vol.37 (11), p.2315-2329

2022

Volltextzugriff (PDF)

NAFLD and NASH in Postmenopausal Women: Implications for Diagnosis and Treatment

Endocrinology (Philadelphia), 2020-10, Vol.161 (10), p.1

DiStefano, Johanna K

2020

Volltextzugriff (PDF)

1 – 25 von 590

Suche als RSS-Feed

Aktive Filter

KollektionOxford University Press Journals Current

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(590)
Mit Volltextzugriff
(564)

Publikationsform

Artikel
(590)

Sprache

Englisch
(590)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Oxford Journals
(590)
Journals@Ovid Complete
(590)
EZB Electronic Journals Library
(550)
MEDLINE
(418)
Oxford Journals 2020 Medicine
(389)
Single Journals
(279)
IngentaConnect Journals
(214)
Wiley Online Library Journals
(182)
Wiley Online Library Full Collection 2018
(171)
PAIS Index
(13)
JSTOR
(8)
IngentaConnect Journals
(6)
Applied Social Sciences Index & Abstracts (ASSIA)
(5)
EBSCOhost Business Source Ultimate
(1)
Sociological Abstracts
(1)

10 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Letter to the Editor: “Cortisol Secretion, Sensitivity, and Activity Are Associated with Hypertension in Postmenopausal Eucortisolemic Women”

High‐Intensity Resistance and Impact Training Improves Bone Mineral Density and Physical Function in Postmenopausal Women With Osteopenia and Osteoporosis: The LIFTMOR Randomized Controlled Trial

The Menopause Transition: Signs, Symptoms, and Management Options

One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study

Review: Diabetes, Obesity, and Cancer—Pathophysiology and Clinical Implications

ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis

Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update

Clinical Features of 24 Patients With Rebound‐Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases

Bone Mineral Density After Transitioning From Denosumab to Alendronate

Early menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: a systematic review and meta-analysis

Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline

FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab

A Single Infusion of Zoledronate in Postmenopausal Women Following Denosumab Discontinuation Results in Partial Conservation of Bone Mass Gains

Calcifediol Is Not Superior to Cholecalciferol in Improving Vitamin D Status in Postmenopausal Women

Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double‐Blind, Phase 2, Parallel Group Study

Secondary Osteoporosis

Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2‐Year Clinical Trial

Reply to Calcifediol Is Not Superior to Cholecalciferol in Improving Vitamin D Status in Postmenopausal Women

Sclerostin Regulation, Microarchitecture, and Advanced Glycation End‐Products in the Bone of Elderly Women With Type 2 Diabetes

Bone‐Forming and Antiresorptive Effects of Romosozumab in Postmenopausal Women With Osteoporosis: Bone Histomorphometry and Microcomputed Tomography Analysis After 2 and 12 Months of Treatment

DDT and Breast Cancer: Prospective Study of Induction Time and Susceptibility Windows

DIAGNOSIS OF ENDOCRINE DISEASE: Evaluation of bone fragility in endocrine disorders

Sex-specific Estrogen Levels and Reference Intervals from Infancy to Late Adulthood Determined by LC-MS/MS

Epidemiology, Pathophysiology, and Genetics of Primary Hyperparathyroidism

NAFLD and NASH in Postmenopausal Women: Implications for Diagnosis and Treatment

Aktive Filter

Suchergebnisse filtern